Fulcrum Pharma PLC
01 February 2008



                               FULCRUM PHARMA PLC

                                 Result of AGM


Fulcrum Pharma plc (AIM: FUL), the drug development and regulatory services
company, announces that, at today's annual general meeting, all resolutions were
duly passed.


For further information, please contact:

Fulcrum Pharma plc
Jon Court, Chief Executive                     Tel: 0870 710 7152

Seymour Pierce
Jonathan Wright                                Tel: 0207 107 8000

About Fulcrum Pharma plc

Fulcrum Pharma plc is a drug development and regulatory services business that
provides global expertise to achieve drug development and regulatory approval
milestones. Fulcrum Pharma offers immediate access to a highly credible,
integrated development team that provides strategic and operational leadership
required to ensure that new drugs move smoothly from discovery research to
product approval.

Fulcrum Pharma is listed on the AIM Market of the London Stock Exchange having
successfully floated in March 2000.



                      This information is provided by RNS
            The company news service from the London Stock Exchange

• News Channel